T1International, an advocacy group for type 1 diabetics, is calling on pharmaceutical companies like Eli Lilly to lower their insulin prices. The group has been pushing these efforts in Indianapolis for several years.

The Inflation Reduction Act gives Medicare historic new powers to lower prescription drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.

A recently approved economic package will lower out-of-pocket costs for some patients. Many who rely on the costly medication say the measure doesn't go far enough.